| Literature DB >> 29269882 |
Melanie Varin1, Marie-Jeanne Kergoat2, Sylvie Belleville2, Gisele Li3,4, Jacqueline Rousseau2, Marie-Hélène Roy-Gagnon1, Solmaz Moghadaszadeh3, Ellen E Freeman5,6,7,8.
Abstract
Studies have found a benefit to living a cognitively active life in older age. Our goal was to quantify participation in cognitively stimulating activities in adults with and without age-related eye disease. We conducted a cross-sectional hospital-based study in Montreal, Canada of older adults (n = 303) having either age-related macular degeneration (AMD) (n = 96), glaucoma (n = 93), or normal vision (n = 114). To be eligible, the AMD group had to have bilateral late stage AMD with a better eye visual acuity of 20/30 or worse. The glaucoma group had to have a diagnosis of bilateral primary open-angle glaucoma with visual field mean deviation < = -4 dB in their better eye. Further inclusion criteria included age ≥ 65 and a Mini-Mental State Exam Blind score ≥ 10. Cognitive activities were measured using the Victoria Longitudinal Study Activity Questionnaire. Linear regression was used. Patients with AMD (β = -4.2, 95% confidence interval (CI) -6.0, -2.4) and glaucoma (β = -1.8, 95% CI -3.3, -0.3) participated in fewer cognitive activities per month compared to those with normal vision after adjusting for age, sex, education, diabetes, number of comorbidities, cognition, and cataract. People with AMD and glaucoma participated in fewer cognitive activities, which could put them at risk for future cognitive impairment.Entities:
Mesh:
Year: 2017 PMID: 29269882 PMCID: PMC5740122 DOI: 10.1038/s41598-017-18419-2
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Description of the study population.
| AMD Mean (SD) or % n = 96 | Glaucoma Mean (SD) or % n = 93 | Normal Vision Mean (SD) or % n = 114 | P-value* | |
|---|---|---|---|---|
| Age, Years | 83.6 (7.0) | 77.5 (8.0) | 72.8 (6.0) | <0.001 |
| Sex | ||||
| Men | 30.2% | 40.9% | 48.3% | 0.003 |
| Women | 69.8% | 59.1% | 51.8% | |
| Education, Years | 10.0 (4.4) | 11.1 (4.2) | 12.5 (4.0) | <0.001 |
| Binocular visual acuity, logMAR | 0.57 (0.40) | 0.21 (0.25) | 0.05 (0.06) | <0.001 |
| Visual field in better eye, MD in dB | −4.2 (4.0)† | −9.0 (7.1) | 0.8 (2.4) | <0.001 |
| Geriatric Depression Scale Score (max: 15) | 3.5 (2.7) | 2.8 (2.9) | 2.1 (2.1) | <0.001 |
| Mini-Mental State Exam Blind Score (max: 22) | 19.7 (2.6) | 20.0 (2.4) | 20.9 (1.4) | <0.001 |
| No. of comorbidities | 3.2 (1.7) | 2.7 (1.7) | 2.7 (1.5) | 0.029 |
| Lens opacity in eye | 22.0% | 18.9% | 29.2% | 0.336 |
SD = standard deviation, MD = mean deviation, dB = decibels, logMAR = log minimum angle of resolution.
*P-value derived from ANOVA or chi-square test.
Description of the sum of activities done at least once per month overall and by subtype of activity.
| Physical Activities Median (IQR) | Self-Maintenance Activities Median (IQR) | Social Activities Median (IQR) | Hobbies and Home Maintenance Median (IQR) | Passive Information Processing Median (IQR) |
|
| |
|---|---|---|---|---|---|---|---|
| Eye Disease Group | |||||||
| Normal Vision | 2.0 (1.0) | 5.0 (1.0) | 2.0 (2.0) | 2.0 (1.0) | 4.0 (1.0) | 9.0 (4.0) | 25.5 (5.3) |
| AMD | 1.0 (2.0) | 5.0 (1.0) | 1.0 (1.0) | 0.0 (1.0) | 4.0 (2.0) | 5.0 (4.0) | 17.6 (5.9) |
| Glaucoma | 1.0 (1.0) | 4.0 (1.0) | 1.0 (1.0) | 1.0 (2.0) | 4.0 (2.0) | 7.0 (4.0) | 22.5 (6.6) |
| Range | 0–6 | 0–6 | 0–5 | 0–7 | 0–6 | 0–16 | 3–40 |
| P-value* | <0.001 | 0.017 | 0.020 | <0.001 | 0.006 | <0.001 | <0.001 |
IQR = inter-quartile range, SD = standard deviation.
*P-value derived from Kruskal-Wallis test (activity subgroups) or from ANOVA (total activities).
Linear regression models of relationships between age-related eye disease and total cognitive activities and subtypes of activities.
| Co-variates | Model 1 Total Cognitive Activities β 95% CI | Model 2 Physical Activities β 95% CI | Model 3 Hobbies and Home Maintenance β 95% CI |
|
|---|---|---|---|---|
| Eye disease group | ||||
| Normal vision | 0.00 | 0.00 | 0.00 | 0.00 |
| AMD | −4.19 −5.96, −2.43* | −0.49 −0.78, −0.20* | −0.59 −1.02, −0.16* | −2.00 −2.90, −1.11* |
| Glaucoma | −1.80 −3.34, −0.26* | −0.26 −0.53, 0.02 | −0.05 −0.49, 0.40 | −0.67 −1.45, 0.12 |
| Age | −0.23 −0.32, −0.13* | −0.01 −0.03, 0.00 | −0.01 −0.04, 0.01 | −0.09 −0.14, −0.04* |
| Female sex | 0.13 −1.17, 1.44 | −0.13 −0.36, 0.10 | −0.12 −0.46, 0.23 | 0.31 −0.37, 0.99 |
| Education | 0.33 0.16, 0.49* | −0.00 −0.03, 0.03 | 0.07 0.03, 0.12* | 0.29 0.21, 0.37* |
| Number of Comorobidities | −0.02 −0.42, 0.38 | −0.00 −0.07, 0.07 | −0.04 −0.15, 0.07 | −0.06 −0.26, 0.14 |
| Diabetes | −1.42 −2.94, 0.10 | −0.20 −0.48, 0.07 | 0.05 −0.33, 0.42 | −0.50 −1.26, 0.26 |
| Cataract | 0.57 −0.91, 2.05 | 0.07 −0.18, 0.31 | 0.22 −0.14, 0.58 | −0.05 −0.73, 0.63 |
| MMSE-Blind Score | 0.38 0.06, 0.70* | 0.06 0.02, 0.11* | −0.01 −0.10, 0.08 | 0.12 −0.07, 0.30 |
*P < 0.05.